Nicolas Béry
Centre National de la Recherche Scientifique(FR)Inserm(FR)Université Fédérale de Toulouse Midi-Pyrénées(FR)Centre de Recherche en Cancérologie de Toulouse(FR)Centre de Recherche en Cancérologie de Toulouse(FR)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Epigenetics and DNA Methylation, Pancreatic and Hepatic Oncology Research, Adenosine and Purinergic Signaling, Ubiquitin and proteasome pathways
Most-Cited Works
- → NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies(2016)317 cited
- → Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds(2019)137 cited
- → Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment(2018)130 cited
- → A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS(2020)126 cited
- → Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange(2017)106 cited
- → KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe(2019)93 cited